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Summary.-The frequency of M-components was studied by agar gel electrophoresis
in sera from 807 patients, 467 (570,,) females and 340 (4301) males with histologically
proven solid malignant neoplasms.
M-components were found in the sera of 40 male and 20 female patients. Apart
from two known cases of multiple myeloma and one case of Waldenstrom's macro-
globulinaemia, none of the patients were found to be suffering from these diseases.
The frequency of M-components increased with age, and this was more evident in
males. Twenty-two of60 patients with M-components did not exhibit abnormalities
on immunoelectrophoresis. Of the 35 remaining patients, 27 had an abnormal
component of the IgG class, 6 of the IgA and 2 of the IgM class. M-components
were found in the sera of patients with a wide variety of neoplasms. There appeared
to be no evidence of an increased frequency of M-components in the sera of patients
with solid malignant neoplasms compared with normal adult population.
M-COMPONENTS are monoclonal immu-
noglobulins which can be identified as
discrete homogenous proteins on eleetro-
phoresis of serum and urine. They are
considered by structural criteria to be
normal immunoglobulins, although they
are still often referred to as " parapro-
teins ".
Until recent years the finding of
M-components in the serum was consid-
ered to be almost exclusively associated
with multiple myeloma, or WAaldenstr6m's
macroglobulinaemia. However, with more
widespread use of electrophoretic tech-
niques, M-components have been demon-
strated in sera from patients who in spite
of thorough investigation did not appear
to be suffering from either of these
diseases, and who did not develop them
when followed up for a considerable
period of time (Waldenstrom, 1964; Zaw-
adzki and Edwards, 1967; Migliore and
Alexanian, 1968; Axelsson and Hallen,
1972).
More recently, the incidence of M-com-
ponents has been studied in the sera of
normal healthy adult population and in
different age groups (Hallen, 1963; Fine,
Derycke and Boffa, 1965; Axelsson, Bach-
mann and Hallen, 1966; Axelsson and
Hallen, 1972). During the last two
decades M-components have been detected
in the sera of patients suffering from
malignant lymphoma (Azar, Hill and
Osserman, 1957; Krauss and Sokal, 1966;
Moore et al., 1970), other forms of malig-
nant disease (Osserman and Takatsuki,
1963; Hallen, 1966; Causey, 1967; Hosley,
1967; Migliore and Alexanian, 1968), and
some non-malignant diseases (Owen, Pit-
ney and O'Dea, 1959; Waldenstrom,
1964; Michaux and Heremans, 1969;
Kanoh, 1970).
In view of the fact that M-components
have been observed in patients with
malignant diseases, it was decided to
study their frequency in the sera
of patients with histologically proven
solid malignant neoplasms attending our
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FIG. 1. The three immunoelectrophoretic patterns observed in our patients with M-components in the serum. (a) a strong precipitation line, consistent with the presence ofa monoclonal immuno-
globulin of the IgG class; (b) a suspect pattern showing a split IgG precipitation line; (c) a
normal pattern.
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MATERIAL AND METHODS
During a period of 13 months from March
1970 to April 1971 all new patients attending
our Institute had a specimen of blood taken
for electrophoretic examination. The popu-
lation studied consisted of all new patients
with proven malignant disease (both out-
patients and in-patients), except for those
with cutaneous neoplasms and leukaemia.
At the same time all histological preparations
relating to these patients were reviewed
independently. When the histological mat-
erialwasfoundto beunsatisfactory and better
preparations could not be obtained, the case
was excluded from the study.
All sera were screened for the presence
of M-components by agar gel electrophoresis
using the method of Wieme (1959). Every
specimen of serum which showed appear-
ances suggesting the presence ofan M-compo-
nent was investigated further. This invest-
igation consisted of immunoelectrophoresis
of the serum using the method of Schei-
degger (1955). At the same time the elec-
trophoresis on agar gel was repeated, and the
presence of an M-component in this specimen
was a prerequisite for considering the serum
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as pbsitive. All M-components encountered
were included.
The results showed that the sera examined
exhibited 3 possible patterns, namely (1) a
strong precipitation line, consistent with the
presence of a monoclonal immunoglobulin
(" paraprotein "); (2) a pattern which al-
though it did not exhibit a definite " para-
protein " showed certain abnormalities, which
were considered to be suspect; and (3) a
pattern free from any abnormalities (Fig. 1).
RESULTS
After exclusion of cases in which
adequate histological material was not
available the patient population under
study consisted of 807 patients. There
were 340 (43%) males and 467 (57 %)
females; the age and sex distribution of
the patients is shown in Fig. 2. The
histological diagnoses of the neoplasms
found in the patients under study, the
incidence of M-components, as well as
the results of immunoelectrophoresis are
shown in Table I.
Femoles (467)
E patients without M-components (447)
B potients with M-components (20)
10 20 30 40 50 60 70 80 90 100
(years)
FIG. 2.- Age and sex distribution of the patients.
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TABLE II. Frequency of M-cornponents in Different Age Groupps
Age (years)
Number of Male
patients and
frequency (%) Female
31-40 41-50 51-60 61-70 71-80 81-90
1 (3 8) 6 (7 7) 13 (12-0) 16 (19-7) 4 (33 3)
1 (2 9) 3 (3 6) 8 (7-1) 2 (1-7) 3 (3 6) 3 (11-5)
Serum electrophoresis revealed the
presence of M-components in 60 patients:
40 males and 20 females. The age
distribution of these patients is shown in
Fig. 2. The frequency of M-components
was found to increase with age, and this
was more evident in males (Table II).
Two patients with multiple myeloma
and one patient with Waldenstrom's
macroglobulinaemia diagnosed during the
period under study were included. No
other patient showed evidence of being
affected by these diseases, and a special
attempt was made to exclude this possi-
bility in the patients with M-components
in the serum.
Of the 60 patients with M-components
11, including 2 with multiple myeloma
and one with Waldenstrom's macro-
globulinaemia, were found to have a
" paraprotein " (Fig. 1(a)). The typing
of these immunoglobulins was as follows:
7 IgG (6 kappa and 1 lambda), 3 IgA and
1 IgM.
Twenty-four patients were found to
have a " suspect " pattern (Fig. 1(b)). The
typing of these immunoglobulins was as
follows: 20 IgG, 3 IgA and 1 IgM. Twenty-
two patients with M-components in the
serum were found to have no abnormali-
ties on immunoelectrophoresis (Fig. 1(c)).
In all these patients the M-components
were weak. In 3 patients with M-com-
ponents, immunoelectrophoresis was not
performed; in all 3 the M-component
present formed a weak band.
M-components were found in the sera
of patients with a wide variety of neo-
plasms (Table I). An increased frequency
of M-components was found in patients
with carcinomata of the lung and urinary
bladder. Twenty-one patients whose sera
contained an M-component were dead by
the end of the period under study.
DISCUSSION
This investigation was undertaken as a
screening study in order to determine the
frequency of M-components in the sera
ofpatients with solid malignant neoplasms
and to see whether there is a specific
pattern. The patients attended a hospital
concerned mainly with radiation therapy
and the study may therefore suffer from
a number of disadvantages associated
with this type of investigation. The
patient population studied is thus selec-
ted in the way that patients with neo-
plasms which are treated by radiotherapy
predominate. In order to avoid any
further selection, all patients with neo-
plastic disease attending the hospital
during the period under study were
included, except those with cutaneous
neoplasms and leukaemia. This explains
the inclusion of patients with multiple
myeloma and Waldenstrom's macroglo-
bulinaemia, diseases normally associated
with the presence of M-components. A
considerable number of patients with
malignant lymphoma, a group of diseases
which is known to be sometimes associated
with the presence of M-components (Azar
et al., 1957; Krauss and Sokal, 1966;
Moore et al., 1970) were also included. In
order to determine their significance all
M-components observed in the sera of the
patients studied were included. The fre-
quency of M-components in the present
study (70 0%) is very much higher than
that observed by Migliore and Alexanian
(1968), who found an incidence of 0-65 %
studying a similar population, except
that patients with cutaneous neoplasms
and a small number with benign neo-
plasms were included. Although this can
be attributed partly to the inclusion of
all M-components as detected by a sensi-
tive technique, even the frequency of
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" paraproteiiis " in the present study is
higher (10%).
If all the cases with immunoelectro-
phoretic abnormalities are included, the
frequency is 4 0%. Among the patients
with M-components there was a male
predominance of nearly 2: 1 (1 85: 1),
although female patients made up 57 %
of patients in the present study. There
was a similar male predominance (1 75: 1)
among the patients with M-components
studied by Migliore and Alexanian (1968),
whose patient populatioin was composed
of 56% female patients. In a study to
determine the frequency ofM-components
in a normal adult population Axelsson
et al. (1966) found a male predomiinance
of 12: 1 in a population consisting of
51 % females and a frequency of 0 9 %,
using a less sensitive technique than that
used in the present study or by Migliore
and Alexanian (1968). Axelsson's results
(1966) are thus higher than those of
Migliore and Alexanian (1968) and are
probably similar to those observed in the
present study, as the frequency of M-com-
ponents in their study is similar to the
frequency of "paraproteins" in the
present study.
Our results support the findings of
Hallen (1963), Fine et al. (1965), Axelsson
et al. (1966), and Finie, Lambin and
Leroux (1972), who have reported that
the incidence of M-components increases
with age.
In the present study, in 22 out of 60
patients with M-components in the serum
there were no abnormalities on immuno-
electrophoresis. In all these cases the
M-components were found to be weak,
and there appears to be a relationship
between the intensity ofthe M-component
and the presence or absence of immuno-
electrophoretic abnormalities. The M-
components which were found were mostly
of the IgG class, but a number of M-com-
ponents of the IgA and one of the IgM
class were also encountered, the patients
with multiple myeloma and Walden-
strom's macroglobulinaemia having been
excluded. These results are similar to
the findings ofWaldenstrom (1964), Axels-
son et al. (1966), Hallen (1966) and Fine
(1970). Migliore and Alexanian (1968)
in their study did not encounter M-com-
ponents of the IgA class, whereas the
majority of the M-components found in
patients with malignant neoplasms studied
by Kanoh (1970) were of this class. This
shows that there is no specific pattern
in the immunoelectrophoretic results
obtained by different investigators.
An important difference between the
M-components encountered in multiple
myeloma, Waldenstrom's macroglobuli-
naemia and some cases of malignant
lymphoma, and those observed in patients
with other neoplasms, non-neoplastic dis-
eases and in the normal population is the
intensity of the abnormal band and the
concentration of the M-component in the
serum. While in the former conditions
the concentration of the M-component
is usually relatively high and shows a
gradual increase, in the latter it is usually
low, producing a weak band and showing
no significant rise when followed up over
a long period of time (Migliore and Alexa-
nian, 1968; Axelsson and Hallen, 1972).
There appears to be no uniform or specific
pattern as far as the location of the
malignant neoplasms in patients with
M-components is concerned, and neo-
plasms of many different organs have
been encountered. Osserman and Takat-
suki (1963) found that in their 31 patients
the tumours were located mainly in t>e
large intestine, nasopharynx and biliary
tract. In the series reported by Migliore
and Alexanian (1968) the most common
sites were the breast, lungs, upper respira-
tory tract and large intestine. The num-
ber of patients with different neoplasms
included in their study was not stated and
therefore the actual frequency cannot be
ascertained. Review of the literature
failed to reveal any studies in which such
information was given. In the present
study, M-components were found in the
sera of patients with neoplasms of many
different organs. There was an increased
frequency in patients with carcinoma of
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the lung and urinary bladder. This find-
ing may be of interest, although its
significance is not certain.
It has been stated by Hallen (1966)
that the incidence of M-components in
patients with malignant neoplasms, with
the exception of multiple myeloma, Wal-
denstrom's macroglobulinaemia and
malignant lymphoma, is not higher than
in normal Swedish population. Migliore
and Alexanian (1968) have stated that
there is no evidence of an increased
frequency of M-components in sera from
patients with malignant neoplasms com-
pared with a normal adult population.
Although the results of the present
study indicate that the frequency of
M-components in sera from patients with
malignant neoplasms is higher than that
found by Migliore and Alexanian (1968),
there appears to be no evidence that it is
higher than in a normal adult population.
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